Induction of leukemic stem cell differentiation by aryl hydrocarbon receptor agonist and synergy with gilteritinib in FLT3-ITD + acute myeloid leukemia-Reference-Cited by-同舟云学术

Induction of leukemic stem cell differentiation by aryl hydrocarbon receptor agonist and synergy with gilteritinib in FLT3-ITD + acute myeloid leukemia

Published:2020-05-06 Issue:8 Volume:61 Page:1932-1942
ISSN:1042-8194
Container-title:Leukemia & Lymphoma
language:en
Short-container-title:Leukemia & Lymphoma

Author:

Han Heejoo¹²^ORCID,Shin Dong-Yeop³^ORCID,Kim Dongchan¹²^ORCID,Kim Hyungsuk⁴,Lee Chansup¹⁵,Koh Youngil²³^ORCID,Hong Junshik¹²³^ORCID,Yoon Sung-Soo¹³⁵

Affiliation:

1. Seoul National University College of Medicine, Seoul, Republic of Korea;

2. Center for Medical Innovation, Seoul National University Hospital, Seoul, Republic of Korea;

3. Department of Internal Medicine, Seoul National University Hospital, Seoul, Republic of Korea;

4. Department of Laboratory Medicine, Seoul National University Hospital, Seoul, Republic of Korea;

5. Cancer Research Institute, Seoul National University College of Medicine, Seoul, Republic of Korea

Publisher

Informa UK Limited

Subject

Cancer Research,Oncology,Hematology

Link

https://www.tandfonline.com/doi/pdf/10.1080/10428194.2020.1747062

Reference32 articles.

1. ‘Acute myeloid leukemia: a comprehensive review and 2016 update’

2. Acute Myeloid Leukemia

3. Mutation profiling of 16 candidate genes in de novo acute myeloid leukemia patients

4. Mutations in AML: prognostic and therapeutic implications

5. Understanding of leukemic stem cells and their clinical implications

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Monocytic Differentiation in Acute Myeloid Leukemia Cells: Diagnostic Criteria, Biological Heterogeneity, Mitochondrial Metabolism, Resistance to and Induction by Targeted Therapies;International Journal of Molecular Sciences;2024-06-08

2. Monocytic Differentiation of Human Acute Myeloid Leukemia Cells: A Proteomic and Phosphoproteomic Comparison of FAB-M4/M5 Patients with and without Nucleophosmin 1 Mutations;International Journal of Molecular Sciences;2024-05-07

3. Differentiating Acute Myeloid Leukemia Stem Cells/Blasts;Reference Module in Biomedical Sciences;2024

4. Non-Toxicological Role of Aryl Hydrocarbon Receptor in Obesity-Associated Multiple Myeloma Cell Growth and Survival;Cancers;2023-11-01

5. Acute myeloid leukemia: therapeutic targeting of stem cells;Expert Opinion on Therapeutic Targets;2022-06-02